Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA approves BEI's ThermAblator sheath changes:

This article was originally published in Clinica

Executive Summary

The US FDA has given BEI Medical Systems the green light to incorporate cost-saving modifications to the way that it assembles the sheath used in its Hydro ThermAblator (HTA) procedure set for treating excessive menstrual bleeding. "The allowance of this modification is an important step in our ongoing objective to reduce production costs of the HTA single-patient-use procedure set, which is expected to result in eventual savings of approximately 50% as production volumes accelerate," said the Teterboro, New Jersey firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064458

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel